Test Price
2,800 AED✅ Home Collection Available
MALT1 Gene Immunodeficiency Type 12 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary: We guarantee 99.9% diagnostic accuracy via ISO 9001:2015 accredited next-generation sequencing, with VIP mobile phlebotomy for home collection (8 AM–11 PM), complimentary post-test telephonic guidance by a DHA-licensed medical geneticist, and direct insurance billing verification via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Hospital-Grade Home Collection (8 AM–11 PM) with ISO-Certified Cold-Chain and VIP Mobile Phlebotomy.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance to interpret results with a DHA-licensed specialist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced Genetic Test thoroughly screens the entire MALT1 gene for pathogenic variants associated with combined immunodeficiency type 12, guiding personalized management for dermatological, osteological, and immunological manifestations. Our clinical-grade next-generation sequencing (NGS) platform delivers single-nucleotide and copy number variant detection with 99.9% analytical sensitivity.
| Feature | Our MALT1 NGS Test | Standard Gene Panel (Alternative) |
|---|---|---|
| Precision | Full Gene Sequencing (single-nucleotide & copy number variants) with 99.9% analytical sensitivity | Targeted hotspot regions; may miss deep intronic or structural variants |
| Methodology | Clinical-Grade NGS (Next Generation Sequencing), CAP/ISO-compliant bioinformatics | Limited Sanger sequencing or microarray-based screening |
| Turnaround Time | 3–4 Weeks (with expedited reporting available) | 4–6 Weeks; may require reflex testing |
Physician Insight & Safety Protocols
“A positive MALT1 variant requires careful clinical correlation. As a DHA-licensed consultant medical geneticist, I emphasize that this test is a powerful tool for early risk stratification, particularly for combined immunodeficiency with cutaneous and EBV-driven complications. Always interpret results within the full clinical and family history—do not delay specialist evaluation if symptoms develop.”
— Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403)
Medication Advisory
Do not discontinue any prescribed immunosuppressive, dermatologic, or antineoplastic medication without consulting your treating physician. Genetic test results are not a substitute for clinical management decisions. Always maintain your current therapy regimen until advised otherwise by your specialist.
Patient Safety Exclusions & Red Flags
- Exclusion Criteria: Active hemolytic anemia, recent blood transfusion within 4 weeks, or high-dose corticosteroid therapy altering lymphocyte subsets.
- Exclusion Criteria: Individuals under 18 years must be accompanied by a legal guardian, with consent obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: If you experience sudden onset high-grade fever, severe lymphadenopathy, or unexplained rapid weight loss, seek emergency care immediately—these may indicate EBV-driven lymphoma.
Patient FAQ & Clinical Guidance
1. What does the MALT1 Genetic Test detect and who should consider it?
This test identifies pathogenic variants in the MALT1 gene causing combined immunodeficiency type 12, aiding diagnosis of recurrent infections, eczema, and osteopenia. It is recommended for individuals with chronic mucocutaneous candidiasis, unexplained lymphoproliferation, or a family history of early-onset immunodeficiency. Dermatologists, immunologists, and geneticists often order it when clinical features suggest a CID phenotype. A genetic counselling session is mandatory before testing to build a pedigree and ensure informed consent.
2. How is the sample collected and when will I receive my results?
A simple blood draw or FTA card dried blood spot is collected by a certified phlebotomist during a home visit within 24 hours of booking. The sample undergoes high-coverage NGS sequencing in our ISO 9001:2015 accredited laboratory. Turnaround time is 3 to 4 weeks; an expedited report is available upon request. All samples are transported in cold-chain validated containers, preserving DNA integrity. You will receive a secure digital report reviewed by a consultant medical geneticist.
3. What do positive results mean for my future health and family?
A positive result confirms a genetic predisposition to severe immunodeficiency, requiring lifelong specialist follow-up and possible prophylactic interventions. It does not guarantee you will develop all symptoms, but it increases risk for EBV-driven lymphomas, autoimmune cytopenias, and invasive infections. Family cascade testing is strongly recommended. Our post-test telephonic guidance will connect you with a DHA-licensed immunologist to create a personalized surveillance plan, including periodic hematologic and imaging assessments.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data are stored on servers within the UAE under DHA License No. 1143. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | MALT1 Gene Sequencing – Combined Immunodeficiency Type 12 |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks (expedited option available) |
| Sample Type / Matrix | Peripheral Whole Blood or FTA Card Dried Blood Spot |
| Methodology Used | Next Generation Sequencing (NGS) – Exon and flanking intronic regions |
| ICD-10-CM Code | D81.8 (Other combined immunodeficiencies) |
| LOINC Code | 81247-9 (Hereditary disease sequence variant detection panel) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
Available 8 AM – 11 PM • DHA-Licensed Phlebotomists
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians